Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Shufang Liu, Sara C. Humphreys, Kevin D. Cook, Kip P. Conner, Ana R. Correia, Alex W. Jacobitz, Melissa Yang, Ronya Primack, Marcus Soto, Rupa Padaki, Mariusz Lubomirski, Richard Smith, Marissa Mock & Veena A. Thomas. (2023) Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice. mAbs 15:1.
Read now
Read now
Stephanie Maciuba, Gregory D. Bowden, Harrison J. Stratton, Kazimierz Wisniewski, Claudio D. Schteingart, Juan C. Almagro, Philippe Valadon, Joshua Lowitz, Scott M. Glaser, Grace Lee, Mahdi Dolatyari, Edita Navratilova, Frank Porreca & Pierre J.M. Rivière. (2023) Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders. mAbs 15:1.
Read now
Read now
Romain Ollier, Aline Fuchs, Florence Gauye, Katarzyna Piorkowska, Sébastien Menant, Monisha Ratnam, Paolo Montanari, Florence Guilhot, Didier Phillipe, Mickael Audrain, Anne-Laure Egesipe, Damien Névoltris, Tamara Seredenina, Andrea Pfeifer, Marie Kosco-Vilbois & Tariq Afroz. (2023) Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework. mAbs 15:1.
Read now
Read now
Monica L. Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif T. Gjølberg, Timothy P. Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty & Andreas H. Laustsen. (2023) Assessing developability early in the discovery process for novel biologics. mAbs 15:1.
Read now
Read now
Karelle Ménochet, Hongbin Yu, Bonnie Wang, Jay Tibbitts, Cheng-Pang Hsu, Amrita V. Kamath, Wolfgang F. Richter & Andreas Baumann. (2022) Non-human primates in the PKPD evaluation of biologics: Needs and options to reduce, refine, and replace. A BioSafe White Paper. mAbs 14:1.
Read now
Read now
Eva Germovsek, Ming Cheng & Craig Giragossian. (2021) Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings. mAbs 13:1.
Read now
Read now
Boris Grinshpun, Nels Thorsteinson, Joao NS Pereira, Friedrich Rippmann, David Nannemann, Vanita D. Sood & Yves Fomekong Nanfack. (2021) Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies. mAbs 13:1.
Read now
Read now
Amol A. Raje, Vallabh Mahajan, Vishal V. Pathade, Kaushal Joshi, Ashutosh Gavali, Ashwani Gaur & Vishwottam Kandikere. (2020) Capillary microsampling in mice: effective way to move from sparse sampling to serial sampling in pharmacokinetics profiling. Xenobiotica 50:6, pages 663-669.
Read now
Read now
Delphine Valente, Christine Mauriac, Thorsten Schmidt, Ingo Focken, Jochen Beninga, Brian Mackness, Huawei Qiu, Pascale Vicat, Abdullah Kandira, Katarina Radošević, Srini Rao, John Darbyshire & Mostafa Kabiri. (2020) Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models. mAbs 12:1.
Read now
Read now
Benjamin E. Low, Gregory J. Christianson, Emily Lowell, Wenning Qin & Michael V. Wiles. (2020) Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human FCGRT transgenic mice. mAbs 12:1.
Read now
Read now
Thomas E. Kraft, Wolfgang F. Richter, Thomas Emrich, Alexander Knaupp, Michaela Schuster, Andreas Wolfert & Hubert Kettenberger. (2020) Heparin chromatography as an in vitro predictor for antibody clearance rate through pinocytosis. mAbs 12:1.
Read now
Read now
Shan Chung, Van Nguyen, Yuwen Linda Lin, Julien Lafrance-Vanasse, Suzie J. Scales, Kevin Lin, Rong Deng, Kathi Williams, Gizette Sperinde, Juan Jenny Li, Kai Zheng, Siddharth Sukumaran, Devin Tesar, James A. Ernst, Saloumeh Fischer, Greg A. Lazar, Saileta Prabhu & An Song. (2019) An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans. mAbs 11:5, pages 942-955.
Read now
Read now
Alison Betts, Anne Keunecke, Tamara J. van Steeg, Piet H. van der Graaf, Lindsay B. Avery, Hannah Jones & Jan Berkhout. (2018) Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach. mAbs 10:5, pages 751-764.
Read now
Read now
Wolfgang F. Richter, Gregory J. Christianson, Nicolas Frances, Hans Peter Grimm, Gabriele Proetzel & Derry C. Roopenian. (2018) Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. mAbs 10:5, pages 803-813.
Read now
Read now
Lindsay B. Avery, Jason Wade, Mengmeng Wang, Amy Tam, Amy King, Nicole Piche-Nicholas, Mania S. Kavosi, Steve Penn, David Cirelli, Jeffrey C. Kurz, Minlei Zhang, Orla Cunningham, Rhys Jones, Brian J. Fennell, Barry McDonnell, Paul Sakorafas, James Apgar, William J. Finlay, Laura Lin, Laird Bloom & Denise M. O'Hara. (2018) Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics. mAbs 10:2, pages 244-255.
Read now
Read now
Nicole M. Piche-Nicholas, Lindsay B. Avery, Amy C. King, Mania Kavosi, Mengmeng Wang, Denise M. O'Hara, Lioudmila Tchistiakova & Madan Katragadda. (2018) Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics. mAbs 10:1, pages 81-94.
Read now
Read now
Charlotte Bon, Thomas Hofer, Alain Bousquet-Mélou, Mark R. Davies & Ben-Fillippo Krippendorff. (2017) Capacity limits of asialoglycoprotein receptor-mediated liver targeting. mAbs 9:8, pages 1360-1369.
Read now
Read now
Di Zhang, Anthony A. Armstrong, Susan H. Tam, Stephen G. McCarthy, Jinquan Luo, Gary L. Gilliland & Mark L. Chiu. (2017) Functional optimization of agonistic antibodies to OX40 receptor with novel Fc mutations to promote antibody multimerization. mAbs 9:7, pages 1129-1142.
Read now
Read now
Miroslav Dostalek, Thomayant Prueksaritanont & Robert F. Kelley. (2017) Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates. mAbs 9:5, pages 756-766.
Read now
Read now
Maria Myzithras, Tammy Bigwarfe, Hua Li, Erica Waltz, Jennifer Ahlberg, Craig Giragossian & Simon Roberts. (2016) Utility of immunodeficient mouse models for characterizing the preclinical pharmacokinetics of immunogenic antibody therapeutics. mAbs 8:8, pages 1606-1611.
Read now
Read now
Articles from other publishers (48)
Trang T. Vu, Kyeongmin Kim, Millennium Manna, Justin Thomas, Bryan C. Remaily, Emma J. Montgomery, Travis Costa, Lauren Granchie, Zhiliang Xie, Yizhen Guo, Min Chen, Alyssa Marie M. Castillo, Samuel K. Kulp, Xiaokui Mo, Sridhar Nimmagadda, Paul Gregorevic, Dwight H. Owen, Latha P. Ganesan, Thomas A. Mace, Christopher C. Coss & Mitch A. Phelps. (2024) Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia. Pharmacological Research 199, pages 107048.
Crossref
Crossref
Yuu Okura, Yuri Ikawa-Teranishi, Akihiko Mizoroki, Noriyuki Takahashi, Takashi Tsushima, Machiko Irie, Zulkarnain Harfuddin, Momoko Miura-Okuda, Shunsuke Ito, Genki Nakamura, Hiroaki Takesue, Yui Ozono, Masamichi Nishihara, Kenta Yamada, Siok Wan Gan, Akira Hayasaka, Shinya Ishii, Tetsuya Wakabayashi, Masaru Muraoka, Nishiki Nagaya, Hiroshi Hino, Takayuki Nemoto, Taichi Kuramochi, Takuya Torizawa, Hideaki Shimada, Takehisa Kitazawa, Makoto Okazaki, Junichi Nezu, Ludvig M. Sollid & Tomoyuki Igawa. (2023) Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease. Nature Communications 14:1.
Crossref
Crossref
Anja Seckinger, Sara Majocchi, Valéry Moine, Lise Nouveau, Hoang Ngoc, Bruno Daubeuf, Ulla Ravn, Nicolas Pleche, Sebastien Calloud, Lucile Broyer, Laura Cons, Adeline Lesnier, Laurence Chatel, Anne Papaioannou, Susana Salgado-Pires, Sebastian Krämer, Ines Gockel, Florian Lordick, Krzysztof Masternak, Yves Poitevin, Giovanni Magistrelli, Pauline Malinge, Limin Shang, Sonja Kallendrusch, Klaus Strein & Dirk Hose. (2023) Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers. Journal of Hematology & Oncology 16:1.
Crossref
Crossref
Adriana Martinez Ledo, Thomas Dimke, William R. Tschantz, David Rowlands & Ellena Growcott. (2023) The role of airway mucus and diseased pulmonary epithelium on the absorption of inhaled antibodies. International Journal of Pharmaceutics 647, pages 123519.
Crossref
Crossref
Miki Yokoyama, Eiko Suzuki, Masataka Oitate & Nobuaki Watanabe. (2023) A Quantitative Prediction Method for the Human Pharmacokinetics of Fc-Fusion Proteins. European Journal of Drug Metabolism and Pharmacokinetics 48:5, pages 541-552.
Crossref
Crossref
Wilhelmus E. A. de Witte, Lindsay B. Avery, Brian C. Mackness, Tom Van Bogaert, Anna Park & Maria Laura Sargentini-Maier. (2023) Mechanistic incorporation of FcRn binding in plasma and endosomes in a whole body PBPK model for large molecules. Journal of Pharmacokinetics and Pharmacodynamics 50:3, pages 229-241.
Crossref
Crossref
Christopher M. Conner, Don van Fossan, Kristen Read, Dale O. Cowley, Oscar Alvarez, Shannon Xiang-Ru Xu, David R. Webb & Kurt Jarnagin. (2023) A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studies. Biochemical Pharmacology 210, pages 115470.
Crossref
Crossref
Akanksha Behl, Zahoor A. Wani, Nagendra Nath Das, Virinder S. Parmar, Christophe Len, Shashwat Malhotra & Anil K. Chhillar. (2023) Monoclonal antibodies in breast cancer: A critical appraisal. Critical Reviews in Oncology/Hematology 183, pages 103915.
Crossref
Crossref
Melanie Grandits, Clemens Grünwald-Gruber, Silke Gastine, Joseph F. Standing, Rajko Reljic, Audrey Y-H. Teh & Julian K-C. Ma. (2023) Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use. Frontiers in Plant Science 14.
Crossref
Crossref
Michael Y.T. Chow, Harry W. Pan, Han Cong Seow & Jenny K.W. Lam. (2023) Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections. Trends in Pharmacological Sciences 44:2, pages 85-97.
Crossref
Crossref
Nia Toshkova, Violeta Zhelyazkova, Sune Justesen & Jordan D. Dimitrov. (2023) Conservative pattern of interaction of bat and human IgG antibodies with FcRn. Developmental & Comparative Immunology 139, pages 104579.
Crossref
Crossref
Michael W. Leach & Katherine Hammerman. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
175
230
.
Rafaella Silva Brito, Aryelle Canedo, Davi Farias & Thiago Lopes Rocha. (2022) Transgenic zebrafish (Danio rerio) as an emerging model system in ecotoxicology and toxicology: Historical review, recent advances, and trends. Science of The Total Environment 848, pages 157665.
Crossref
Crossref
Baoshan Zhang, Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee, Mangaiarkarasi Asokan, Eun Sung Yang, Amarendra Pegu, Bob C. Lin, Cara W. Chao, Xuejun Chen, Lucio Gama, Vera B. Ivleva, William H. Law, Cuiping Liu, Mark K. Louder, Stephen D. Schmidt, Chen-Hsiang Shen, Wei Shi, Judith A. Stein, Michael S. Seaman, Adrian B. McDermott, Kevin Carlton, John R. Mascola, Peter D. Kwong, Q. Paula Lei & Nicole A. Doria-Rose. (2022) Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life. Scientific Reports 12:1.
Crossref
Crossref
Elisabeth Narayanan, Samantha Falcone, Sayda M. Elbashir, Husain Attarwala, Kimberly Hassett, Michael S. Seaman, Andrea Carfi & Sunny Himansu. (2022) Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1. Antibodies 11:4, pages 67.
Crossref
Crossref
Stephen H. Curry & Robin Whelpton. 2022. Drug Disposition and Pharmacokinetics. Drug Disposition and Pharmacokinetics
194
219
.
K. J. MoiseJrJr, D. Oepkes, E. Lopriore & R. G. M. Bredius. (2022) Targeting neonatal Fc receptor: potential clinical applications in pregnancy. Ultrasound in Obstetrics & Gynecology 60:2, pages 167-175.
Crossref
Crossref
Kathryn Ball, Gerard Bruin, Enrique Escandón, Christoph Funk, Joao N.S. Pereira, Tong-Yuan Yang & Hongbin Yu. (2022) Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper. Drug Metabolism and Disposition 50:6, pages 858-866.
Crossref
Crossref
Jayaprakasam Bolleddula, Kevin Brady, Gerard Bruin, Anthony Lee, Jennifer A. Martin, Markus Walles, Keyang Xu, Tong-Yuan Yang, Xiaochun Zhu & Hongbin Yu. (2022) Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives. Drug Metabolism and Disposition 50:6, pages 837-845.
Crossref
Crossref
Sandra Wymann, Marcel Mischnik, David Leong, Subhajit Ghosh, Xiahui Tan, Helen Cao, Benjamin Kuehnemuth, Glenn A. Powers, Partho Halder, Mitchell J. de Souza, Hannah S. James, Vesna Tomasetig, Holger Lind, Paolo Rossato, Catherine M. Owczarek, Saw Yen Ow, Steven K. Dower, Adriana Baz Morelli, Tony Rowe & Matthew P. Hardy. (2022)
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity
in vivo
. Biochemical Journal 479:9, pages 1007-1030.
Crossref
Crossref
Kenta Haraya, Haruka Tsutsui, Yasunori Komori & Tatsuhiko Tachibana. (2022) Recent Advances in Translational Pharmacokinetics and Pharmacodynamics Prediction of Therapeutic Antibodies Using Modeling and Simulation. Pharmaceuticals 15:5, pages 508.
Crossref
Crossref
Yutong Liu, Alison G. Lee, Annalee W. Nguyen & Jennifer A. Maynard. (2022) An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH. Journal of Biological Chemistry 298:4, pages 101798.
Crossref
Crossref
Lauren E. Himmel, Kristin Lewis Wilson, Sara F. Santagostino & Brad Bolon. 2022. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
859
924
.
Daniela Bumbaca Yadav, Kapil Gadkar & Isabel Figueroa. 2022. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
77
100
.
Anna Kaempffe, Stephan Dickgiesser, Nicolas Rasche, Andrea Paoletti, Elisa Bertotti, Ilse De Salve, Federico Riccardi Sirtori, Roland Kellner, Doreen Könning, Stefan Hecht, Jan Anderl, Harald Kolmar & Christian Schröter. (2021) Effect of Conjugation Site and Technique on the Stability and Pharmacokinetics of Antibody-Drug Conjugates. Journal of Pharmaceutical Sciences 110:12, pages 3776-3785.
Crossref
Crossref
Sheila Annie Peters. 2021. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations
225
262
.
Chang Liu, Yeon Su Kim, John Hok-Nin Lowe & Shan Chung. (2021) A cell-based FcRn-dependent recycling assay for predictive pharmacokinetic assessment of therapeutic antibodies. Bioanalysis 13:14, pages 1135-1144.
Crossref
Crossref
Maxime Fieux, Sandra Le Quellec, Sophie Bartier, André Coste, Bruno Louis, Caroline Giroudon, Mikail Nourredine & Emilie Bequignon. (2021) FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review. International Journal of Molecular Sciences 22:12, pages 6475.
Crossref
Crossref
Joshua D. Berwanger, Hui Yin Tan, Gia Jokhadze & Merlin L. Bruening. (2021) Determination of the Serum Concentrations of the Monoclonal Antibodies Bevacizumab, Rituximab, and Panitumumab Using Porous Membranes Containing Immobilized Peptide Mimotopes. Analytical Chemistry 93:21, pages 7562-7570.
Crossref
Crossref
Miho Nagayasu & Kazuhisa Ozeki. (2021) Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic mice. Pharmaceutical Research 38:4, pages 583-592.
Crossref
Crossref
Timothy Qi & Yanguang Cao. (2021) In Translation: FcRn across the Therapeutic Spectrum. International Journal of Molecular Sciences 22:6, pages 3048.
Crossref
Crossref
Genki Nakamura, Kazuhisa OzekiHiroaki TakesueMitsuyasu TaboKen-ichi Hosoya. (2021) Prediction of Human Pharmacokinetics Profile of Monoclonal Antibody Using hFcRn Transgenic Mouse Model. Biological and Pharmaceutical Bulletin 44:3, pages 389-395.
Crossref
Crossref
Sanghwan Ko, Migyeong Jo & Sang Taek Jung. (2021) Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering. BioDrugs 35:2, pages 147-157.
Crossref
Crossref
Brian Geist, Songmao Zheng & Yan Xu. 2021. Remington. Remington
437
462
.
Hannah M. Jones, John Tolsma, Zhiwei Zhang, Paul Jasper, Haobin Luo, Gregory L. Weber, Katherine Wright, Joel Bard, Robert Bell, Dean Messing, Kerry Kelleher, Nicole Piche‐Nicholas & Robert Webster. (2020) A Physiologically‐Based Pharmacokinetic Model for the Prediction of “Half‐Life Extension” and “Catch and Release” Monoclonal Antibody Pharmacokinetics. CPT: Pharmacometrics & Systems Pharmacology 9:9, pages 534-541.
Crossref
Crossref
Kip P. Conner, Siva Charan Devanaboyina, Veena A. Thomas & Dan A. Rock. (2020) The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation. Pharmacology & Therapeutics 212, pages 107574.
Crossref
Crossref
Genki Nakamura, Kazuhisa OzekiMiho NagayasuTakeru NambuTakayuki NemotoKen-ichi Hosoya. (2020) Predicting Method for the Human Plasma Concentration–Time Profile of a Monoclonal Antibody from the Half-life of Non-human Primates. Biological and Pharmaceutical Bulletin 43:5, pages 823-830.
Crossref
Crossref
Charles G Starr & Peter M Tessier. (2019) Selecting and engineering monoclonal antibodies with drug-like specificity. Current Opinion in Biotechnology 60, pages 119-127.
Crossref
Crossref
Amita Datta-Mannan. (2019) Mechanisms Influencing the Pharmacokinetics and Disposition of Monoclonal Antibodies and Peptides. Drug Metabolism and Disposition 47:10, pages 1100-1110.
Crossref
Crossref
Hannah M. Jones, Zhiwei Zhang, Paul Jasper, Haobin Luo, Lindsay B. Avery, Lindsay E. King, Hendrik Neubert, Hugh A. Barton, Alison M. Betts & Robert Webster. (2019)
A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From
In Vitro
Data
. CPT: Pharmacometrics & Systems Pharmacology 8:10, pages 738-747.
Crossref
Crossref
Yao-Yun Fan, Vahid Farrokhi, Teresa Caiazzo, Mengmeng Wang, Denise M. O’Hara & Hendrik Neubert. (2019) Human FcRn Tissue Expression Profile and Half-Life in PBMCs. Biomolecules 9:8, pages 373.
Crossref
Crossref
Kenneth W. Walker, Hossein Salimi-Moosavi, Gregory E. Arnold, Qing Chen, Marcus Soto, Frederick W. Jacobsen & John Hui. (2019) Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates. PLOS ONE 14:5, pages e0217061.
Crossref
Crossref
Douglas Leipold & Saileta Prabhu. (2018) Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies. Clinical and Translational Science 12:2, pages 130-139.
Crossref
Crossref
Kenta Haraya, Tatsuhiko Tachibana & Tomoyuki Igawa. (2019) Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering. Drug Metabolism and Pharmacokinetics 34:1, pages 25-41.
Crossref
Crossref
Weijing Liu, Austin L. Bennett, Wenjing Ning, Hui-Yin Tan, Joshua D. Berwanger, Xiangqun Zeng & Merlin L. Bruening. (2018) Monoclonal Antibody Capture and Analysis Using Porous Membranes Containing Immobilized Peptide Mimotopes. Analytical Chemistry 90:20, pages 12161-12167.
Crossref
Crossref
E. Sally Ward & Raimund J. Ober. (2018) Targeting FcRn to Generate Antibody-Based Therapeutics. Trends in Pharmacological Sciences 39:10, pages 892-904.
Crossref
Crossref
Sari LatvalaBjoern JacobsenMichael B. OttenederAnnika HerrmannSven Kronenberg. (2017) Distribution of FcRn Across Species and Tissues. Journal of Histochemistry & Cytochemistry 65:6, pages 321-333.
Crossref
Crossref
Amrita V. Kamath. (2016) Translational pharmacokinetics and pharmacodynamics of monoclonal antibodies. Drug Discovery Today: Technologies 21-22, pages 75-83.
Crossref
Crossref